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Abstract
Background: There is increasing interest in the environmental and health consequences of silver nanoparticles as
the use of this material becomes widespread. Although human exposure to nanosilver is increasing, only a few
studies address possible toxic effect of inhaled nanosilver. The objective of this study was to determine whether
very small commercially available nanosilver induces pulmonary toxicity in mice following inhalation exposure.
Results: In this study, mice were exposed sub-acutely by inhalation to well-characterized nanosilver (3.3 mg/m
3,
4 hours/day, 10 days, 5 ± 2 nm primary size). Toxicity was assessed by enumeration of total and differential cells,
determination of total protein, lactate dehydrogenase activity and inflammatory cytokines in bronchoalveolar
lavage fluid. Lungs were evaluated for histopathologic changes and the presence of silver. In contrast to published
in vitro studies, minimal inflammatory response or toxicity was found following exposure to nanosilver in our in
vivo study. The median retained dose of nanosilver in the lungs measured by inductively coupled plasma - optical
emission spectroscopy (ICP-OES) was 31 μg/g lung (dry weight) immediately after the final exposure, 10 μg/g
following exposure and a 3-wk rest period and zero in sham-exposed controls. Dissolution studies showed that
nanosilver did not dissolve in solutions mimicking the intracellular or extracellular milieu.
Conclusions: Mice exposed to nanosilver showed minimal pulmonary inflammation or cytotoxicity following sub-
acute exposures. However, longer term exposures with higher lung burdens of nanosilver are needed to ensure
that there are no chronic effects and to evaluate possible translocation to other organs.
Background
With increasing use of manufactured nanoparticles the
potential for exposure among manufacturers and consu-
mers is also increasing. Many of these manufactured
nanomaterials are composed of metal and metal oxides
and there have been reports of metal-containing nano-
particles in workplaces [1], from industrial sources
detected in the atmosphere [2,3] and in surface waters
[4,5]. Silver nanoparticles, often referred to as nanosil-
ver, may be problematic because of their use in a wide
range of applications due to their antimicrobial activity
[6-8]. Nanosilver is used for treatments of wounds,
b u r n s ,w a t e ro ra i rd i s i n f e c t i o n ,o ra sc o a t i n g so nv a r -
ious textiles [9]. There is concern that little is known
about the environmental and health consequences of
exposure to nanosilver.
Prior in vitro studies of nanosilver toxicity [10-15]
reveal toxic effects of nanosilver through reduced cell via-
bility, damage to the cell membrane and other biological
effects on the organism. Nanosilver has been reported to
be among the most toxic nanomaterials in some studies
[10,16-18]. The cytotoxicity of nanosilver has been asso-
ciated with generation of reactive oxygen species [10,19]
and several studies suggest that nanosilver is only toxic
when oxidized to silver ions, Ag
+ [12,14].
Most of the in vitro studies show dose dependence,
where higher doses of Ag induce higher cellular toxicity.
In contrast to in vivo investigations, in vitro concentra-
tions of nanoparticles are often much higher and the par-
ticles are delivered to the cells via the culture medium.
Such exposures do not replicate the conditions expected
for in vivo exposure. Currently, there is no direct correla-
tion of biological markers of toxicity between in vivo and
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mono- vs. co-cultures, endpoint evaluations as well as
other factors of cellular interaction with different biologi-
cal media [20,21]. Even though air-liquid in vitro systems
have been recently developed that may have more predic-
tive value [22-25], in vivo studies are still considered to
be more relevant for risk assessment.
Although inhalation is considered the most important
route of exposure for nanoparticles [26,27], little is
known about the environmental and health risks of
aerosolized nanosilver [28]. There are a few reports in
the literature on pulmonary studies of nanosilver toxi-
city in rats [7,29-32]. In these studies silver was detected
in the lungs and, at much lower concentration, in the
liver, brain, olfactory bulb and blood indicating organ
translocation of nanosilver. No significant health impli-
cations were found for short exposure time periods
although some pathologic responses were observed for
higher Ag doses or longer exposures, such as chronic
alveolar inflammation, small granulomatous lesions, and
a decrease in the tidal and minute volume of the lungs.
However, there are significant gaps in the toxicity stu-
dies of nanosilver and more thorough investigations
with well characterized materials are warranted [6].
An integrated approach that includes both inhalation
toxicology studies and full characterization of the nano-
materials is necessary for understanding inflammatory
responses as they relate to the physicochemical princi-
ples of nanoparticle toxicity. In the current study, such
an approach is used to assess the potential toxic effects
associated with the inhalation of commercial nanosilver
using a murine model for lung inflammation, histo-
pathology, and dosimetry.
Materials and methods
Nanoparticles
Nanosilver with a manufacturer’s stated average particle
size of 10 nm (minimum 5 nm, maximum 15 nm, BET=
(10 + 1) m
2/g) were in powder form and used as received
from the manufacturer (Stock # 0478 YD, Nanostruc-
tured and Amorphous Materials, Inc, Houston, TX).
The nanosilver was characterized using transmission
electron microscopy (TEM), X-ray diffraction (XRD),
X-ray photoelectron spectroscopy (XPS), and
BET techniques [33]. The bulk crystalline phases of
Ag nanoparticles were determined using powder XRD
measurements (Bruker D-5000 q - q diffractometer with
Kevex-sensitive detector, Madison, WI). TEM (JEOL
JEM-1230, Japan) was used to measure the primary par-
ticle size of 500 random nanoparticles and compare the
average to manufacturer’s specifications.
Surface properties, surface area, and composition of the
Ag nanoparticles were examined. Surface area measure-
ments of the powder sample were made on automated
multipoint BET surface area apparatus (Quantachrome
Nova 4200e, Boynton Beach, Florida) using nitrogen as
the adsorbent. X-ray photoelectron spectroscopy (XPS)
was used to probe the surface chemical composition
characteristics of the metal nanoparticles (custom-
designed Ultra-Axis XPS system from Kratos, Manche-
ster, UK).
Dissolution studies were conducted in two different
types of artificial fluids using inductively coupled plasma
optical emission spectrometer (ICP-OES) (Varian Inc.
720-ES, Walnut Creek, CA). Ag nanoparticles were
incubated in artificial interstitial fluid (Gamble’ss o l u -
tion, pH = 7.4) and artificial lysosomal fluid (ALF, pH =
4.5) at a concentration of 2 mg/ml for 24 hours at 38°C.
The ALF solution simulates the composition and pH of
alveolar and interstitial macrophages and the Gamble’s
solution simulates interstitial fluid in the lungs [34]. The
compositions of the simulated biological fluids can be
found in Ref. [35]. The final solutions were filtered by a
syringe through 0.2 μm filter and centrifuged for 30 min-
utes at 14,000 rpm in order to remove nanoparticles and
aggregates that were not dissolved. The filtered and cen-
trifuged solutions were analyzed by ICP-OES.
Animals
Male (6 weeks old) C57Bl/6 mice (The Jackson Labora-
tory, Bar Harbor, ME) were quarantined for 12 days
after their arrival in our vivarium in polypropylene,
fiber-covered cages in HEPA-filtered Thoren caging
units (Hazelton, PA) in the Pulmonary Toxicology Facil-
ity at the University of Iowa prior to use. Mice were
supplied with food (sterile Teklad 5% stock diet, Harlan,
Madison, WI) and water ad libitum and maintained on
a 12-hr light-dark cycle. The average weight of the ani-
mals at the time of necropsy was 22.4 g at 0 wk post
exposure and 26.8 g at 3 weeks post exposure. Sham-
exposed control mice had a mean weight of 26.9 g at
the time of necropsy. Protocols were approved by the
Institutional Animal Care and Use Committee at the
University of Iowa and complied with the NIH Guide
for the Care and Use of Laboratory Animals.
Exposure Generation and Characterization
A dynamic whole-body exposure chamber [36] was used
to expose animals to nanosilver. Sham-exposed mice
breathed filtered room air in an identical chamber
setup. A suspension of nanosilver in ultra-pure water
(Milli-Q
® Academic A-10, Millipore Corp., Billerica,
MA) was ultra-sonicated (model 550, Fisher Scientific,
Pittsburgh, PA) for 20 min. Aerosols of this suspension
were generated using a 6-jet Collison nebulizer (BGI
Inc., Waltham, MA) supplied with filtered, pressurized
a i r( 2 4p s i )a n dp a s s e dt h r o u g ha6 0c m×2c m( I . D . ) ,
brass drying column heated to 110°C as well as a
20 mCi
63Ni source to completely evaporate droplets
and neutralize charges on the particles prior to
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concentrations of particles were measured in the cham-
ber using 47-mm glass microfiber filters (Whatman,
Middlesex, United Kingdom) in line with the 24 l/min
exhaust airflow. With the additional heat and humidity
supplied to the chamber, the temperature and relative
humidity in the exposure chamber during the experi-
ments was controlled between 20-22°C and 25-35%,
respectively. Electron microscopy grids were placed
inside the exposure chamber for analysis of deposited
nanoparticles. The grids were analyzed using scanning
electron microscopy with an energy dispersive spectro-
meter (SEM-EDS) (Hitachi S-3400N, Japan) capable of
providing elemental analysis of the particles. This con-
firmed the presence of nanosilver on the grid from the
whole-body chamber during inhalation exposures. The
size distribution of the aerosol in the whole-body expo-
sure chamber was measured using a scanning mobility
particle sizer (SMPS, TSI Inc., Shoreview, MN) for dia-
meters in the range of 7.4 to 289 nm. Geometric mean
(GM) and geometric standard deviation (GSD) of aero-
sol sizes in individual exposures were calculated from
SMPS measurements.
Inhalation Exposure
Mice were exposed sub-acutely to nanosilver for
4 hours/day, 5 days/week for 2 weeks and necropsied
within one hour (0 wk) or 3 weeks post exposure
(3 wks). The experimental design of this study is shown
in Figure 1. The average concentration of nanosilver
was 3.3 ± 0.5 mg/m
3 (range = 2.4 - 4.0 mg/m
3). A min-
ute volume of 25 ml and particle deposition fraction (a)
in the tracheo-bronchiolar and pulmonary region of
0.15 [37,38] were assumed to estimate nanosilver dose.
Bronchoalveolar Lavage
Mice were euthanized by isoflurane inhalation and
exsanguination through the heart. Lungs (from 5 ani-
mals per each experimental group) were lavaged 3 times
with 1 ml of 0.9% sterile sodium chloride solution
(Baxter, Deerfield, IL) and the cell pellet was used for
enumeration of total and differential cell counts as pre-
viously described [39]. Cells recovered from bronchoal-
veolar lavage (BAL) fluid were processed for TEM-EDS
analyses (n = 1). Macrophages recovered from BAL fluid
with and without Ag particles (100 cells per sample)
were counted using dark field microscopy to assess the
extent of the phagocytosis. The lavage supernatants (n =
5) were analyzed for total protein in 4 dilutions (1:5,
1:10, 1:20, and 1:40) using a Bradford protein assay
(Bio-Rad Laboratories, Inc., Hercules, CA), lactate dehy-
drogenase (LDH) activity was measured in duplicates
with a commercial assay (Roche Diagnostics, Penzberg,
Germany) and cytokine levels measured by multiplexed
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Figure 1 Schematic of the experimental design used in this study.
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Mouse Cytokine, Chemokine, and Growth Factor Multi-
plex Assays, Bio-Rad Laboratories, Inc., Hercules, CA).
Measured cytokines included: interleukin (IL)-6, IL-12
(p40), tumor necrosis factor (TNF)-a, granulocyte
macrophage colony stimulating factor (GM-CSF), kerati-
nocyte-derived cytokine (KC), monocyte chemotactic
protein (MCP)-1, and macrophage inflammatory protein
(MIP)-1a. The BAL fluid (n = 5) was then centrifuged
again at 22,000 rpm for 30 min and Ag concentration in
BAL supernatants was measured by ICP-MS.
Histopathology
Lungs from non-lavaged mice (n = 3) were fixed in 10%
formaldehyde-phosphate-buffered saline solution via the
canulated trachea. The tissues were paraffin-embedded,
sectioned at 5 μm, and stained with hematoxylin and
eosin (H & E) as previously described [25]. Tissue sec-
tions were evaluated by light microscopy to elucidate
abnormalities of the parenchymal architecture (bronch-
ioles, alveoli, pleura, and vasculature); abnormal inflam-
matory infiltrates; presence or absence of acute lung
injury; and presence or absence of fibrosis.
Nanosilver dosimetry
Lung, brain, heart, and liver tissues from 5 mice in each
experimental group were stored at -80°C immediately
after resection. Tissues were lyophilized for 16 hours at
1.3 × 10
-1 mBar and -50°C in a freeze dryer (Labconco
Corp., Kansas City, MO) and then weighted. High purity
concentrated nitric acid (Fisher Optima
® grade) was
used to digest the tissues at 95-98°C. Metal analysis was
performed using ICP-OES (Varian 720 ES, Varian Inc.,
Walnut Creek, CA) with a method detection limit for
Ag of 1.8 μg/g lung dry weight (d.w.).
EDS-spectra of Ag nanoparticles in alveolar macrophages
The BAL cells were fixed with2 . 5 %g l u t a r a l d e h y d ei n
0.1M Na cacodylate buffer, post fixed with 1% osmium
tetroxide, dehydrated through graded ethanols and
embedded in epoxy resin. Thins sections were cut at
~80-90 nm on a Leica EM UC6 ultramicrotome (Leica
Microsystems GmbH, Wetzlar, Germany) and placed on
200 mesh formvar/carbon coated nickel grids. Elemental
analysis of the cells recovered from BAL was performed
with a Thermo Fisher Noran System 7 (Waltham, MA)
energy dispersive spectroscopy system (EDS) attached to
a JOEL JEM-2100F (Tokyo, Japan) field emission trans-
mission electron microscope. The TEM was operated at
an accelerating voltage of 200 kV in scanning mode
combined with a high angle annular field detector
(HAADF). NSS 2.2 software package was used to
acquire and process the data.
Statistical Analyses
Data from nanosilver-exposed and sham-exposed ani-
mals were compared using t tests for equal or unequal
variances (SAS Ver. 9.2, SAS, Inc., Cary, NC). A p-value
less than 0.05 was considered significant. Data are
expressed as mean ± standard error (SE) unless other-
wise noted.
Results
Particle Characterization
The results of particle characterization are summarized
in Figure 2 and Table 1. The XRD patterns in Figure 2A
compare the nanosilver results with metallic silver and
silver oxide (Ag2O, AgO) reference spectra and demon-
strate that the nanoparticles are metallic silver with no
detectable silver oxide. Surface composition was also
examined using XPS (Figure 2B) to test for the presence
of an oxide surface layer. Peaks in the Ag3d, Ag3p, O1s,
and C1s regions of the photoelectron spectrum were
identified. The Ag3d doublet at 368.2 eV and 374.2 eV
is consistent with silver in the Ag
0 oxidation state. The
O1s region does not show any oxygen peaks below 530
eV attributable to AgO or Ag2O, but there is a peak due
to CO3
2- at 530.7 eV. There are also unique peaks at
287.3 and 288.7 eV which we attribute to C=O and
CO3
2-, respectively. In summary, the XPS data indicate
the presence of adventitious carbon, some carbon-
oxygen functionality, likely due to the use of polyvinyl-
pyrrolidone (PVP) during synthesis to control particle
size, and Ag2CO3 on the surface of the nanosilver, but
no evidence of a silver oxide coating. This coating
accounts for up to 17% of the nanoparticle mass, as
determined by ICP analysis and corresponds to a coat-
ing thickness of approximately 0.7 nm. A presence of
PVP on Ag nanoparticles surface diminishes the propen-
sity of nanoparticles towards aggregation [40] and shows
a minimal effect on the Ag nanoparticles toxicity against
prokaryotic bacteria [12]. The specific surface area of
nanosilver was determined to be 3 ± 2 m
2/g using
multi-point BET analysis and is lower than the manufac-
turer’s specified specific surface area of 10 ± 1 m
2/g.
A primary particle size distribution was generated
from the TEM images (Figure 2C) by measuring the
two-dimensional diameter of more than 500 nanoparti-
cles (Figure 2D). The first mode of the bimodal particle
size distribution with a peak maximum at 5 nm
accounted for 85 to 90% of the total particle count. The
second mode, with a peak at 22 nm, was attributed to
larger particles that account for less than 15% of the
total particle count.
The dissolution of Ag nanoparticles into Ag ions in ALF
and Gamble’s solution was studied using ICP-OES [34].
The bioavailability and toxicity of metal nanoparticles are
often linked to the ability of the nanoparticles to deliver
soluble metal ions to the surrounding tissue. Figure 3
shows that nanosilver dissolved less than 0.1% in either
simulated biological fluid in 24 hours. The concentrations
of Ag ions were measured in triplicate in ALF and
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0.03 ± 0.002% and 0.07 ± 0.003%, correspondingly. This is
in contrast to earlier studies on Cu nanoparticles that fully
dissolved in ALF and showed 2% dissolution in Gamble’s
solution [34].
SEM-EDS of the particles collected on TEM grids in
the whole body chamber showed nanosilver aerosol
between 50 and 100 nm detected at the characteristic
X-ray energy for Ag (Figure 4). The size distributions of
Ag nanoparticle aerosols measured during exposure
Figure 2 A. Powder X-ray diffraction patterns for nanosilver with patterns shown for three reference compounds including Ag, AgO
and AgO2. B. X-ray photoelectron spectrum for nanosilver. C. TEM image of nanosilver and D. particle primary diameter count distribution from
TEM images.
Table 1 Summary of physicochemical characterization data of Ag nanoparticles and Ag nanoparticle aerosols
Primary Particle Size* TEM 5 ± 2 nm; 22 ± 4 nm
Crystalline or Amorphous Material, phase XRD Crystalline, face-centered cubic, metal
Surface Functionality XPS CO3
2-,O H
-, C=O, C-O-C
BET Surface Area BET 3 ± 2 m
2/g
Aerosol Concentration Gravimetric Analysis 3.3 ± 0.5 mg/m
3
Aerosol Size Distribution** SMPS 79 nm (1.5)
* Bimodal distribution with smaller particles account for 85-90% of the total particle count.
**GM, nm, (GSD) in exposure chamber.
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GM mobility diameter of 79 nm and GSD of 1.5 (Table
1). These measurements show that mice were exposed to
agglomerates of nanosilver that were larger than the pri-
mary nanoparticles.
Sub-acute Exposure
The median amount of silver measured by ICP-OES in the
lungs of nanosilver-exposed mice necropsied immediately
after the exposure (0 wk group) was 31 μg/g lung (d.w.)
(range 4.3 to 37.5 μg/g lung (d.w.)). This represents the
loading in the lungs but not the nose, nasopharynx or tra-
chea, which were not measured. The lungs of the 3 wk
mice had a median silver content of 10 μg/g lung (d.w.),
and two of these five mice had no detectable silver. The
mass concentration of silver in all sham-exposed mice was
below the detection limit (1.8 μg/g lung (d.w.)). Silver
concentrations in the heart, liver, and brain were all below
the detection limit. Assuming a minute volume of 25 ml/
min, an aerosol concentration of 3.3 mg/m
3 and a deposi-
tion coefficient of 0.15 in the tracheo-bronchiolar and pul-
monary region, we estimate that 803 μg Ag/g lung (d.w.)
was delivered to the lungs. Thus, 4% of the nominal Ag
dose was found in the pulmonary region.
Bronchoalveolar Lavage Fluid
The total number of cells per mouse in BAL fluid was
significantly increased in Ag-exposed mice necropsied at
0w k( 9 2 . 3±3 . 7×1 0
3) and 3 wks (119.2 ± 18.7 × 10
3)
post exposure, compared to sham-exposed mice (50.1 ±
8.4 × 10
3). As shown in Figure 5A, the number of neutro-
phils per mouse in BAL fluid was significantly increased
in mice necropsied at 0 wk and 3 wks post exposure (p <
0.05). However, this change was of little biological signifi-
cance. Additionally, there was no significant change in
total cell numbers between mice necropsied at 0 wk and
3 wks post exposure (Figure 5B). These results are in
contrast to the effects of exposure to 12 nm copper nano-
particles with a copper oxide coating using the same pro-
tocol and with a similar airborne concentration
(3.68 mg/m
3) [34]. Data for copper shown for compari-
son in Figures 5A and 5B indicate a substantial recruit-
ment of cells to the lungs and a substantial increase in
total protein leaking from the epithelium. These resolved
considerably after 3 wks without exposure.
We did not find significant differences between groups
in total protein levels and activity of LDH in BAL fluid
(Figure 5B). Concentrations of the following cytokines
measured in BAL fluid were below the limit of detec-
tion: IL-6, TNF-a, MCP-1, MIP-1a,G M - C S F( T a b l e2 ) .
We found slight, though statistically significant, eleva-
tion in IL-12(p40) and KC concentrations in the group
necropsied at 0 wk post exposure compared with sham-
exposed mice (p < 0.05). These concentrations were still
increased, but not significantly in the mice necropsied 3
wks post exposure. In contrast, Cu nanoparticles
induced substantial elevations in MCP-1, IL-12(p40),
MIP-1a,K Ca n dT N F a.I L - 6a n dG M - C S Fw e r ea l s o
significantly elevated (Table 2).
The mean concentrations of Ag ion in BAL superna-
tants were 13.9 ± 0.9 μg/L and 1.7 ± 0.2 μg/L in animals
necropsied at 0 wk and 3 wks post exposure, respectively.
Silver was not detectable in BAL fluid from control mice.
No pathologic changes were found in Ag-exposed ani-
mals or sham-exposed mice. No signs of inflammatory cell
infiltrate, alveolitis, perivasculitis, lymphoid agglomerates,
epithelial damage, granulomas, giant cells or fibrosis were
observed. Particle-laden macrophages were found in the
BAL fluid of nanosilver-exposed mice as well as in the
lung parenchyma immediately after the last exposure as
shown using dark field microscopy (Figures 6A) and also
ALF (pH 4.5) Gamble’s (pH 7.4)
Ag
Cu
Figure 3 Dissolution results for Ag and Cu nanoparticles in ALF
and Gamble’s solution after 24 hours at 38°C. Cu nanoparticle
data are from Ref. 34.
Figure 4 SEM-EDS mapping of nanosilver aerosols deposited
on TEM grid during the exposure. The colored dots represent the
elemental map for Ag at the expected characteristic X-ray energy for
Ag and show, based on size, the presence of silver nanoparticle
agglomerates.
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Page 7 of 12Table 2 Cytokine concentrations in BAL fluid from mice exposed to Ag nanoparticles by inhalation. Data from Ref. 34
for Cu nanoparticle exposure using the same protocol are shown for comparison
Exposure IL-6 IL-12(p40) TNF-a KC MCP-1 MIP-1a GM-CSF
Group
Silver pg/ml
Controls ND 29.1 ± 2.9 ND ND ND ND ND
Ag 0 wk post exposure ND 64.1 ± 10.6* ND 4.24 ± 0.88* ND ND ND
Ag 3 wks post exposure ND 53.6 ± 21.9 ND 2.96 ± 0.54 ND ND ND
Detection limit 0.67 0.73 44.3 1.77 9.58 27.31 1.48
Copper pg/ml
Controls ND 35.0 ± 6.8 21.4 ± 3.3 0.90 ± 0.12 ND ND 0.16 ± 0.08
Cu 0 wk post-exposure 82.8 ± 13.8* 1210 ± 10.1* 161 ± 10.4* 215 ± 17.0* 4400 ± 401* 309 ± 37.2* 70.2 ± 10.9*
Cu 3 wk post-exposure ND 42.7 ± 4.8 17.3 ± 1.6 1.44 ± 0.12 ND ND 0.27 ± 0.13
Detection limit 0.11 0.08 13 0.19 3.44 2.01 0.08
ND Not detectable.
* Significantly different from sham-exposed animals (p < 0.05).
Figure 6 Dark field micrographs of alveolar macrophages recovered from BAL fluid prepared by cytospinning and H & E staining
(A, C, E) and lung tissues with H & E staining (B, D, F). Micrographs from animals exposed to nanosilver and necropsied immediately post
exposure (A, B) or 3 weeks post exposure (C, D) and sham-exposed mice (E, F). White arrows point to particle-laden macrophages in lung tissue.
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weeks post exposure there was still evidence of silver parti-
cles in macrophage phagosomes (Figures 6C). However,
there was a higher percentage of macrophages (76%)
found in BAL fluid of mice necropsied at 0 wk post expo-
sure as compared to mice necropsied 3 wks post exposure
(28%).
Discussion
The purpose of this study was to assess the biological
response of mice to inhaled nanosilver and to determine
the amount of silver retained in lungs and other organs.
We observed nanosilver agglomerates in the inhalation
chamber with a GM mobility diameter of 79 nm (Table
1) and SEM-EDS analysis showed the presence of Ag
aerosols in the exposure chamber (Figure 4). ICP-OES
analysis of nanosilver incubated in the simulated biologi-
cal fluids revealed negligible formation of Ag ions (Fig-
ure 3). Moreover, most of the nanoparticles, even PVP
coated particles, aggregated and settled out in these
simulated biological fluids at the relatively high concen-
trations investigated after 24 hours and the XRD analy-
sis of the precipitates revealed the presence of metallic
Ag similar to Figure 2A.
Since there are limited data available on the concen-
trations of nanosilver in consumer products or in the air
in occupational settings where materials with nanosilver
are being produced, we established exposure concentra-
tions in the whole-body chamber that were similar to
our previous studies of toxicity assessment of titanium
dioxide, copper, and iron. This facilitated comparison of
toxicologic responses with our previous studies with dif-
ferent nanomaterials [34,41,42]. The median amount of
silver measured in lungs of nanosilver-exposed mice was
31 and 10 μg / gl u n g( d . w . )f o r0w ka n d3w k sa n i m a l s ,
respectively, which corresponds to 100 μg/L and 32 μg/
L Ag concentrations measured by ICP-OES in the lungs.
Moreover, low Ag concentrations in the particle-free
supernatants of BAL fluid (13.9 ± 0.9 μg/L and 1.7 ± 0.2
μg/L in animals necropsied at 0 wk and 3 wks post
exposure, respectively) were detected by ICP-MS.
Higher concentration of Ag measured in BAL fluid from
animals necropsied at 0 wk agrees with the higher
amount of Ag measured in the 0 wk lungs. Thus, these
data suggest that there is some evidence for Ag dissolu-
tion in the lungs. It has been shown that Ag nanoparti-
cles might fractionate (or dissolve) in aquatic
environments at very low (< 100 μg/L) concentrations
since nanoparticles might be less aggregated than in
higher concentrated samples [43,44].
The amount of Ag detected in the 0 wk group corre-
sponds to the lung burden accumulated by a 70 kg per-
son exposed to a very high concentration of 1.0 mg/m
3
for 16.6 hours. Hence, this represents a substantial dose.
To calculate the exposure time of the human, we
assumed exposure concentration of 1.0 mg/m
3,f r e -
quency of breathing 15 breaths/min, tidal volume of the
lungs 600 mL/breath, pulmonary deposition fraction for
80 nm particles of 0.4 (based on human model by
Cassee et al. [38]) and delivered Ag dose to human 3574
μg. The amount of nanosilver measured from the pul-
monary region of the exposed mice was below the esti-
mated levels based on the minute ventilation, deposition
fraction and gravimetric measurements of chamber out-
flow. This could be due to lower breathing zone concen-
trations for the mice than expected from the chamber
Figure 7 Particles found inside alveolar macrophages were identified using TEM-EDS as silver (A, B).
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tion coefficient for the pulmonary region, clearance by
mucociliary escalator to the trachea or gastrointestinal
tract, translocation of nanosilver to other organs that we
did not measure, or poor sensitivity of the ICP-OES
assay methods. Work by Asgharian and colleagues has
shown that particles below 10 nm are deposited in the
nasopharynx and tracheal regions with little penetration
into the pulmonary region [37]. Deposition occurs pri-
marily through axial transport by diffusion and convec-
tive mixing. Model predictions show that for
nanoparticles in the 80 nm range, the deposition frac-
tion for the pulmonary region is about 0.4 in humans
(for mouth breathing) and 0.15 in rodents which are
obligate nose breathers [38].
We observed increased total cell numbers in Ag-
exposed animals (mainly macrophages) and a slight
inflammatory response (increased number of neutrophils
in BAL fluid) in 0 wk mice (Figures 5). Recruitment of
macrophages is a normal clearance mechanism following
particle exposure [45,46]. Neutrophilia decreased after 3
weeks without exposure, however total number of cells
remained elevated. Interestingly, comparison of these
results to other metal nanoparticle exposures studied by
our group shows that nanosilver is most similar to iron
nanoparticles, which are coated with an iron oxide layer.
In the previous study, iron nanoparticles were found to
be significantly less toxic than copper nanoparticles [34].
Copper nanoparticles induced a 25 times increase in the
number of BAL cells after sub-acute exposure as well as
an increase in most cytokines.
The levels of total protein and LDH activity in BAL
fluid did not change significantly with exposure to
nanosilver (Figure 5B). This is another indication of
low nanosilver toxicity at the exposure concentration
used in this study. Of 7 cytokines tested only two, IL-
12(p40) and KC, had slightly elevated concentrations
at 0 wk and most were below detection even using a
very sensitive assay (Table 2). IL-12(p40), which exhib-
ited the most elevated concentration, functions primar-
ily to induce naïve T-cells to differentiate to Th0 cells
and to enhance NK cell activity. It is produced by den-
dritic cells and macrophages [47]. This is consistent
with the observed doubling in BAL macrophages but is
v e r yl o wi nc o m p a r i s o nt oo ur previous study of Cu
nanoparticles when we detected a mean level of IL-12
(p40) of 1210 pg/ml (Table 2). Keratinocyte-derived
cytokine (KC) that is involved in chemotaxis and cell
activiation of neutrophils, was also slightly elevated.
However, this increase was 50 times lower than in Cu-
exposed mice. Furthermore, other chemokines/cyto-
k i n e ss u c ha sM C P - 1 ,M I P - 1 a,T N F - a,R A N T E S ,G M -
CSF were much more elevated in case of Cu nanopar-
t i c l ee x p o s u r e[ 3 4 ] .
We observed agglomerated nanosilver in macrophages
that were recovered from BAL fluid and also in lung tis-
sue (Figure 6). Dark-field microscopy revealed lower
particle load at 3 wks post exposure than immediately
post exposure, showing some particle clearance or possi-
ble translocation from the airways to the interstitium.
Lung tissues were without remarkable pathological
changes. In a 90 day rat study, lung inflammation and
an increase in granulomatous lesions as well as altera-
tions in lung functions were observed [48]. In another
inhalation study in rats, minimal, toxicologically insignif-
icant effects of nanosilver on the nasal respiratory
mucosa were indicated [49].
Here we used the same experimental mouse model and
exposure system as in our previous studies on the toxicity
of different nanomaterials [34,41,42]. Of all nanomaterials
studied in the size range from ca. 5 to 20 nm (TiO2,F e ,
Cu, Ag), copper nanoparticles, which had a copper oxide
coating, induced much higher total cell and neutrophil
recruitment in BAL fluid, elevated total protein, activity of
LDH and levels of inflammatory cytokines in BAL fluid
than nanosilver [50]. This increased inflammatory
response in copper-exposed mice was associated with the
nanoparticle size and increased ion concentration pro-
duced from the dissolving nanoparticles in vivo.M i c e
exposed sub-acutely to 2-5 nm TiO2 nanoparticles showed
a moderate inflammatory response at 0, 1, and 2 weeks
post-exposure that resolved after 3 weeks post-exposure.
Iron nanoparticles induced a minimal inflammatory
response similar to nanosilver. The toxicity of Ag nano-
particles in this murine inhalation model was similar to Fe
nanoparticles. Both types do not dissolve in artificial inter-
stitial fluid which could be associated with the negligible
toxic response observed for metal and metal oxide nano-
materials. Other studies also support a role for solubility
of nanomaterials in their toxicity [51,52].
Conclusions
The toxicity of nanosilver is a highly debated topic in the
literature and in reports of the U.S. Environmental Pro-
tection Agency. Our study indicates that 40 hr inhalation
of 3.3 mg/m
3 nanosilver induced minimal pulmonary
toxicity or inflammation. Methods used to evaluate toxic
responses in this study indicate much lower inflamma-
tory response of mice to silver nanoparticles than to cop-
per nanoparticles. These observations are in agreement
with other studies, which indicate that much higher
exposure doses of silver nanoparticles than other metals
are needed to induce significant inflammation.
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